V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20215776 | 20181153 | 1.82 | 73.3 | Neo-adjuvant (N) | 2019-11-07 | 2020-05-10 | Oxaliplatin + Modified de Gramont | N | N | OXALIPLATIN + MDG | 101590620 |
| 20215878 | 20181154 | 1.5 | 67.4 | Curative (C) | 2020-11-23 | 2020-12-17 | CARBOPLATIN + PACLITAXEL + RT | 02 | Y | CARBOPLATIN + PACLITAXEL | 100226979 |
| 20215943 | 20181155 | 1.72 | 83.9 | Neo-adjuvant (N) | 2019-03-04 | 2019-03-04 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL | 101049715 |
| 20216024 | 20181156 | 1.69 | 68.2 | Palliative (P) | 2018-08-03 | 2018-08-08 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | CISPLATIN + GEMCITABINE | 101241366 |
| 20216028 | 20181157 | 1.74 | 78.5 | Palliative (P) | 2019-07-31 | 2019-08-12 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | CISPLATIN + GEMCITABINE | 101088180 |
| 20216074 | 20181159 | 1.9 | 56.4 | null | 2021-11-17 | 2021-11-18 | CISPLATIN + GEMCITABINE | N | null | CAPECITABINE + IRINOTECAN | 101290405 |
| 20216094 | 20181160 | 1.68 | 59 | null | 2021-01-27 | 2021-02-25 | Capecitabine (21 day) + Irinotecan | 02 | null | CAPECITABINE + IRINOTECAN | 101138290 |
| 20216110 | 20181161 | 1.59 | 83.1 | Palliative (P) | 2020-07-22 | 2020-07-23 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | CAPECITABINE + IRINOTECAN | 100655310 |
| 20216277 | 20181163 | 1.7 | 80 | Palliative (P) | 2016-01-14 | 2016-08-25 | CAPECITABINE + IRINOTECAN | 02 | N | CAPECITABINE + IRINOTECAN | 101139226 |
| 20216401 | 20181164 | 1.72 | 63.8 | Palliative (P) | 2022-05-05 | 2022-05-16 | CAPECITABINE + IRINOTECAN | 02 | N | CAPECITABINE + IRINOTECAN | 100335388 |
| 20216410 | 20181165 | 1.77 | 109 | null | 2021-11-28 | 2021-11-28 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | CISPLATIN + GEMCITABINE | 101170759 |
| 20216441 | 20181166 | 1.59 | 55.8 | Palliative (P) | 2021-11-26 | 2022-03-12 | CISPLATIN + GEMCITABINE | 02 | N | CISPLATIN + GEMCITABINE | 101643539 |
| 20216538 | 20181167 | 1.66 | 81.3 | Palliative (P) | 2016-12-25 | 2016-12-29 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | DOCETAXEL | 100368325 |
| 20216640 | 20181168 | 1.86 | 74.7 | Palliative (P) | 2019-08-06 | 2019-09-06 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101216275 |
| 20216669 | 20181169 | 1.48 | 71.25 | null | 2021-06-04 | 2021-06-12 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101816080 |
| 20216722 | 20181170 | 1.83 | 76.1 | Palliative (P) | 2018-07-14 | 2018-10-04 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100987004 |
| 20216724 | 20181171 | 1.78 | 68.7 | null | 2017-04-22 | 2017-05-08 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100546967 |
| 20216865 | 20181172 | null | 103.1 | Palliative (P) | 2017-07-29 | 2017-12-16 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101333133 |
| 20217655 | 20181175 | 1.68 | 98 | 02 | 2022-03-24 | 2022-03-28 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101732104 |
| 20217989 | 20181176 | 1.83 | 63 | Palliative (P) | 2018-01-31 | 2018-02-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101038346 |
| 20217992 | 20181177 | 1.59 | 70.05 | 03 | 2019-08-11 | 2019-08-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101860127 |
| 20218010 | 20181178 | 1.59 | 69.3 | Adjuvant (A) | 2021-02-01 | 2021-02-15 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100660882 |
| 20218111 | 20181179 | 1.68 | 106.65 | Neo-adjuvant (N) | 2016-08-29 | 2017-04-27 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100856685 |
| 20218154 | 20181180 | 1.61 | 86.3 | null | 2017-09-07 | 2017-09-07 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100750336 |
| 20218493 | 20181181 | 1.59 | 74 | null | 2019-03-07 | 2019-03-26 | Gemcitabine + Capecitabine | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100056429 |
| 20219015 | 20181183 | 1.68 | 68.85 | null | 2018-09-16 | 2018-10-13 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100687325 |
| 20219081 | 20181184 | 1.76 | 71 | 03 | 2018-01-18 | 2018-10-29 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100398303 |
| 20219389 | 20181185 | 1.93 | 69.3 | Palliative (P) | 2016-02-22 | 2016-07-10 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100561204 |
| 20219732 | 20181186 | 1.75 | 53.1 | Curative (C) | 2019-06-27 | 2019-07-18 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 101424888 |
| 20220179 | 20181188 | 1.7 | 104 | null | 2018-12-06 | 2019-05-11 | Capecitabine + Cisplatin + RT | 02 | null | CAPECITABINE + CISPLATIN | 101150997 |
| 20220243 | 20181189 | 1.82 | 52 | null | 2017-07-17 | 2017-07-17 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 100340220 |
| 20220352 | 20181190 | 1.66 | 76.1 | null | 2018-09-30 | 2018-10-05 | Trastuzumab 21 day maintenance | 02 | null | TRASTUZUMAB | 101225375 |
| 20220624 | 20181191 | 1.84 | 65 | null | null | 2020-03-07 | Trastuzumab | N | null | TRASTUZUMAB | 100526319 |
| 20220747 | 20181192 | 1.92 | 74.4 | Neo-adjuvant (N) | 2021-03-28 | 2021-04-02 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101606636 |
| 20220800 | 20181193 | 1.72 | 88 | null | 2020-06-03 | 2020-07-03 | Capecitabine + Cisplatin | 02 | null | CAPECITABINE + CISPLATIN | 100941969 |
| 20220877 | 20181194 | 0 | 70 | Palliative (P) | 2017-07-20 | 2018-04-07 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN | 100992867 |
| 20221103 | 20181195 | null | 56 | Palliative (P) | 2016-11-27 | 2017-03-28 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101482232 |
| 20221118 | 20181196 | 1.7 | 75 | Curative (C) | 2016-12-30 | 2017-06-01 | CETUXIMAB | 02 | N | CETUXIMAB | 100595490 |
| 20221911 | 20181197 | 1.66 | 63.55 | null | 2017-10-21 | 2017-11-06 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 100526766 |
| 20222025 | 20181198 | 1.52 | 73 | Palliative (P) | 2020-09-21 | 2020-10-03 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | IRINOTECAN + MDG | 100851418 |
| 20223463 | 20181199 | 1.73 | 75 | Neo-adjuvant (N) | 2017-08-30 | 2017-09-27 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100218749 |
| 20223741 | 20181200 | 1.84 | 85.8 | Curative (C) | 2017-03-27 | 2017-03-29 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100284227 |
| 20223899 | 20181201 | 1.65 | 47.9 | Palliative (P) | 2019-02-28 | 2019-08-18 | Irinotecan | 02 | N | IRINOTECAN | 101350599 |
| 20224015 | 20181202 | 1.57 | 75.5 | Adjuvant (A) | 2021-11-16 | 2021-11-25 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100839151 |
| 20224037 | 20181203 | 1.76 | 63.9 | Palliative (P) | 2018-01-19 | 2018-07-22 | Irinotecan + Modified De Gramont | null | N | IRINOTECAN + MDG | 101596662 |
| 20224653 | 20181204 | 1.58 | 49 | Palliative (P) | 2019-08-25 | 2019-08-29 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100633752 |
| 20224935 | 20181205 | 1.8 | 68.8 | null | 2016-10-08 | 2016-10-08 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100659852 |
| 20224959 | 20181206 | 1.71 | 81.4 | Palliative (P) | 2018-10-01 | 2018-11-22 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 101029100 |
| 20001010 | 20181207 | 1.72 | 77 | Palliative (P) | 2019-09-18 | 2019-10-14 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101744577 |
| 20004464 | 20181208 | 1.9 | 86.7 | Adjuvant (A) | null | 2022-03-20 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 101744780 |